The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: Preliminary findings
Dominique Musselman, Erica B. Royster, Ming Wang, Qi Long, Lisa M. Trimble, Tara K. Mann, Daniel S. Graciaa, Marcia D. McNutt, N. S.Freda Auyeung, Lindsay Oliver, David H. Lawson, Andrew H. Miller
Dive into the research topics of 'The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: Preliminary findings'. Together they form a unique fingerprint.